BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30653427)

  • 1. Endothelial Notch1 in Pulmonary Hypertension.
    Babicheva A; Yuan JX
    Circ Res; 2019 Jan; 124(2):176-179. PubMed ID: 30653427
    [No Abstract]   [Full Text] [Related]  

  • 2. Smooth Muscle Contact Drives Endothelial Regeneration by BMPR2-Notch1-Mediated Metabolic and Epigenetic Changes.
    Miyagawa K; Shi M; Chen PI; Hennigs JK; Zhao Z; Wang M; Li CG; Saito T; Taylor S; Sa S; Cao A; Wang L; Snyder MP; Rabinovitch M
    Circ Res; 2019 Jan; 124(2):211-224. PubMed ID: 30582451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.
    Hwangbo C; Lee HW; Kang H; Ju H; Wiley DS; Papangeli I; Han J; Kim JD; Dunworth WP; Hu X; Lee S; El-Hely O; Sofer A; Pak B; Peterson L; Comhair S; Hwang EM; Park JY; Thomas JL; Bautch VL; Erzurum SC; Chun HJ; Jin SW
    Circulation; 2017 Jun; 135(23):2288-2298. PubMed ID: 28356442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypermethylation of BMPR2 Promoter Occurs in Patients with Heritable Pulmonary Arterial Hypertension and Inhibits BMPR2 Expression.
    Liu D; Yan Y; Chen JW; Yuan P; Wang XJ; Jiang R; Wang L; Zhao QH; Wu WH; Simonneau G; Qu JM; Jing ZC
    Am J Respir Crit Care Med; 2017 Oct; 196(7):925-928. PubMed ID: 28170297
    [No Abstract]   [Full Text] [Related]  

  • 8. The BMPR2 missense mutation p.K230N and pulmonary arterial hypertension.
    Hayes D; Ramanathan C; Kopp BT
    Pediatr Pulmonol; 2014 Jan; 49(1):E5-6. PubMed ID: 23139147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMPR2 mutation and outcome in pulmonary arterial hypertension: clinical relevance to physicians and patients.
    Rubin LJ
    Am J Respir Crit Care Med; 2008 Jun; 177(12):1300-1. PubMed ID: 18522952
    [No Abstract]   [Full Text] [Related]  

  • 10. Bone Morphogenetic Protein Receptor Type 2 Mutation in Pulmonary Arterial Hypertension: A View on the Right Ventricle.
    van der Bruggen CE; Happé CM; Dorfmüller P; Trip P; Spruijt OA; Rol N; Hoevenaars FP; Houweling AC; Girerd B; Marcus JT; Mercier O; Humbert M; Handoko ML; van der Velden J; Vonk Noordegraaf A; Bogaard HJ; Goumans MJ; de Man FS
    Circulation; 2016 May; 133(18):1747-60. PubMed ID: 26984938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-implantation genetic diagnosis in pulmonary arterial hypertension due to BMPR2 mutation.
    Frydman N; Steffann J; Girerd B; Frydman R; Munnich A; Simonneau G; Humbert M
    Eur Respir J; 2012 Jun; 39(6):1534-5. PubMed ID: 22654007
    [No Abstract]   [Full Text] [Related]  

  • 13. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
    Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M
    Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-Specific iPSC-Derived Endothelial Cells Uncover Pathways that Protect against Pulmonary Hypertension in BMPR2 Mutation Carriers.
    Gu M; Shao NY; Sa S; Li D; Termglinchan V; Ameen M; Karakikes I; Sosa G; Grubert F; Lee J; Cao A; Taylor S; Ma Y; Zhao Z; Chappell J; Hamid R; Austin ED; Gold JD; Wu JC; Snyder MP; Rabinovitch M
    Cell Stem Cell; 2017 Apr; 20(4):490-504.e5. PubMed ID: 28017794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oestrogen receptor alpha in pulmonary hypertension.
    Wright AF; Ewart MA; Mair K; Nilsen M; Dempsie Y; Loughlin L; Maclean MR
    Cardiovasc Res; 2015 May; 106(2):206-16. PubMed ID: 25765937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted gene delivery of BMPR2 attenuates pulmonary hypertension.
    Reynolds AM; Holmes MD; Danilov SM; Reynolds PN
    Eur Respir J; 2012 Feb; 39(2):329-43. PubMed ID: 21737550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early onset severe pulmonary arterial hypertension with 'two-hit' digenic mutations in both BMPR2 and KCNA5 genes.
    Wang G; Knight L; Ji R; Lawrence P; Kanaan U; Li L; Das A; Cui B; Zou W; Penny DJ; Fan Y
    Int J Cardiol; 2014 Dec; 177(3):e167-9. PubMed ID: 25189502
    [No Abstract]   [Full Text] [Related]  

  • 20. BMPR2 gene mutation in pulmonary arteriovenous malformation and pulmonary hypertension: a case report.
    Handa T; Okano Y; Nakanishi N; Morisaki T; Morisaki H; Mishima M
    Respir Investig; 2014 May; 52(3):195-8. PubMed ID: 24853021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.